Condition
Enlarged Prostate With Lower Urinary Tract Symptoms
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03337048Not ApplicableCompleted
Exploratory Study Investigating Urodynamic Parameters During Catheterisation
NCT06491108Phase 3RecruitingPrimary
Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
NCT05470751Completed
GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
NCT03055624Not ApplicableCompleted
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Showing all 4 trials